Sakar Healthcare

Sakar Healthcare Current Liabilities

The Current Liabilities of Sakar Healthcare (SAKAR.NS) as of Nov 5, 2026 is 1.10 B INR. In the previous year, Current Liabilities was 746.06 M INR — a change of 46.82% (higher).

Current Liabilities

1.10 BINR

YoY

46.82%

Last updated:

Current Liabilities of Sakar Healthcare is 2026 1.10 B INR. Current Liabilities of Sakar Healthcare was 2025 746.06 M INR. It decreases by 46.82% higher compared to the previous year.

The Sakar Healthcare Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
144.03 M INR
Jan 1, 2020
121.11 M INR
Jan 1, 2021
256.45 M INR
Jan 1, 2022
386.60 M INR
Jan 1, 2023
511.77 M INR
Jan 1, 2024
683.41 M INR
Jan 1, 2025
746.06 M INR
Jan 1, 2026
1.10 B INR
The Sakar Healthcare Current Liabilities history
YEARCurrent LiabilitiesYoY
1.10 BINR+46.82%
746.06 MINR+9.17%
683.41 MINR+33.54%
511.77 MINR+32.38%
386.60 MINR+50.75%
256.45 MINR+111.74%
121.11 MINR-15.91%
144.03 MINR-10.27%
160.51 MINR+29.59%
123.86 MINR+69.18%
73.21 MINR-28.45%
102.32 MINR-29.89%
145.95 MINR+20.21%
121.41 MINR+39.92%
86.77 MINR-18.83%
106.90 MINR-0.88%
107.84 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sakar Healthcare Stock analysis

What does Sakar Healthcare do? Sakar Healthcare Ltd. manufactures pharmaceutical products including liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectables (SVP) in ampoules and vials, lyophilized injections, and oral solid dosages. The company operates as a contract development and manufacturing organization (CDMO) providing these products under brand names such as Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin - Oral Solid, and Lyophilised Injections (In Vials). Sakar Healthcare serves markets in 14 countries including Uganda, Kenya, Yemen, Ethiopia, Congo, Zimbabwe, Nigeria, Malawi, Philippines, Peru, Vietnam, and Cote D’Ivoire with approximately 321 product registrations. The company generates revenue through the sale of these pharmaceutical products to healthcare providers and distributors in these regions. The firm’s manufacturing unit is accredited by regulatory authorities in 14 countries, which enables it to produce and distribute products across these markets. Sakar Healthcare’s product portfolio includes liquid injectables (SVP) in ampoules and vials, dry powder injections, and oral solid dosages, which are sold to healthcare facilities and pharmacies. The company’s contracts with clients in the pharmaceutical sector involve developing and manufacturing products according to their specifications, with the firm’s focus on cephalosporin-based medications and liquid formulations. Sakar Healthcare Ltd. focuses on providing contract manufacturing services for pharmaceutical products, with a strong emphasis on cephalosporin formulations and liquid-based medications. The company’s products are registered in 321 product registrations across various countries, supporting its operations in 14 regulatory markets. Revenue is derived from the production and sale of these registered products to healthcare providers and distributors in the regions where it holds regulatory accreditation. Sakar Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sakar Healthcare stock

Current Liabilities of Sakar Healthcare is 1.10 B INR in 2026.

Current Liabilities of Sakar Healthcare changed from 746.06 M INR to 1.10 B INR, representing a 46.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Sakar Healthcare since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Sakar Healthcare historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sakar Healthcare

All Key Metrics — Sakar Healthcare